Net shares · 365d
-60.5K
0 buy · 60.5K sell
Net value · 365d
-$1.1M
$0 in · $1.1M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
8
0 buy · 60.5K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$0
5.5K sh
Own +15%
-
BCAX Sell·S
Chief Medical Officer · 10b5-1
$125.8K
5.5K sh · $22.88
Own -9%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$20.8K
5.5K sh · $3.79
Own +10%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$0
5.5K sh
Own +13%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$20.8K
5.5K sh · $3.79
Own +10%
-
BCAX Sell·S
Chief Medical Officer · 10b5-1
$104.2K
5.5K sh · $18.95
Own -9%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$0
16.5K sh · 2 lots
Own +45%
-
BCAX Sell·S
Chief Medical Officer · 10b5-1
$305.6K
16.5K sh · $18.52 avg · 2 lots
Own -23%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$62.5K
16.5K sh · $3.79 avg · 2 lots
Own +30%
-
BCAX Grant·A
Chief Medical Officer
$0
100.0K sh
Own New
-
BCAX Exercise·M
Chief Medical Officer
$0
19.8K sh
Own +25%
-
BCAX Exercise·M
Chief Medical Officer
$75.0K
19.8K sh · $3.79
Own +56%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$0
11.0K sh · 3 lots
Own +10%
-
BCAX Sell·S
Chief Medical Officer · 10b5-1
$205.1K
11.0K sh · $18.65 avg · 3 lots
Own -24%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$41.7K
11.0K sh · $3.79 avg · 3 lots
Own +38%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$0
22.0K sh
Own +21%
-
BCAX Sell·S
Chief Medical Officer · 10b5-1
$405.9K
22.0K sh · $18.45
Own -38%
-
BCAX Exercise·M
Chief Medical Officer · 10b5-1
$83.4K
22.0K sh · $3.79
Own +62%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Apr 27, 2026 | BCAX | Exercise M | 5.5K | $0 |
| Apr 27, 2026 | BCAX | Sell S | 5.5K | $125.8K |
| Apr 27, 2026 | BCAX | Exercise M | 5.5K | $20.8K |
| Mar 25, 2026 | BCAX | Exercise M | 5.5K | $0 |
| Mar 25, 2026 | BCAX | Exercise M | 5.5K | $20.8K |
| Mar 25, 2026 | BCAX | Sell S | 5.5K | $104.2K |
| Mar 4, 2026 | BCAX | Exercise M | 16.5K2 lots | $0 |
| Mar 4, 2026 | BCAX | Sell S | 16.5K2 lots | $305.6K |
| Mar 4, 2026 | BCAX | Exercise M | 16.5K2 lots | $62.5K |
| Feb 2, 2026 | BCAX | Grant A | 100.0K | $0 |
| Dec 26, 2025 | BCAX | Exercise M | 19.8K | $0 |
| Dec 26, 2025 | BCAX | Exercise M | 19.8K | $75.0K |
| Nov 25, 2025 | BCAX | Exercise M | 11.0K3 lots | $0 |
| Nov 25, 2025 | BCAX | Sell S | 11.0K3 lots | $205.1K |
| Nov 25, 2025 | BCAX | Exercise M | 11.0K3 lots | $41.7K |
| Oct 9, 2025 | BCAX | Exercise M | 22.0K | $0 |
| Oct 9, 2025 | BCAX | Sell S | 22.0K | $405.9K |
| Oct 9, 2025 | BCAX | Exercise M | 22.0K | $83.4K |
Buy Sell Non-market (grant · exercise · gift)
About Raben David
This profile aggregates every SEC Form 4 insider transaction reported by Raben David across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.